HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICCR Will Have Growing Role In Setting Global Policy – Industry Groups

This article was originally published in The Rose Sheet

Executive Summary

Following the International Cooperation on Cosmetics Regulation’s eighth meeting in Ottawa, representatives from trade groups PCPC and CCTFA spoke with “The Rose Sheet” about ICCR’s progress to date and its growing influence on regulation within core member jurisdictions, as well as with other stakeholders around the world.

You may also be interested in...



Fourth Time’s A Charm? President’s FY 2016 Budget Includes Cosmetic Fees

Continuing what has become a familiar refrain, the Obama administration’s fiscal 2016 budget request for FDA includes cosmetics user fees, marking the fourth consecutive year that such a system has been proposed. Legislation would need to be introduced – and passed – in order to establish cosmetics user fees.

FDA Studies Trace Element Content In Cosmetics; Guidance To Come?

In a study recently published in the Journal of Cosmetic Science, FDA assessed levels of seven trace contaminants in 150 cosmetic products on the market. The agency says the survey will help it to “make appropriate decisions regarding elemental contaminants in cosmetics.”

Existing Safety Principles Suffice For Nano-Cosmetics Evaluation – FDA

FDA maintains that the current framework for cosmetic safety assessment is sufficient to control potential risks associated with nano-engineered cosmetics. However, traditional testing methods may need to be modified or new strategies developed to account for nanomaterials’ unique properties and behavior, the agency says in final guidance issued June 24.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019144

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel